Last reviewed · How we verify
Toxoplasmosis associated with acquired immunodeficiency syndrome
Approved treatments
- Sulfadiazine · Eli Lilly
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Toxoplasmosis associated with acquired immunodeficiency syndrome patent landscape — cliff calendar, originator estates, attackable patents
- Toxoplasmosis associated with acquired immunodeficiency syndrome treatment landscape brief
- Toxoplasmosis associated with acquired immunodeficiency syndrome treatment updates RSS
Frequently asked questions about Toxoplasmosis associated with acquired immunodeficiency syndrome
What drugs treat Toxoplasmosis associated with acquired immunodeficiency syndrome?
Tracked treatments include Sulfadiazine.
What is the treatment for Toxoplasmosis associated with acquired immunodeficiency syndrome?
Standard treatment for Toxoplasmosis associated with acquired immunodeficiency syndrome includes Sulfadiazine. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Toxoplasmosis associated with acquired immunodeficiency syndrome patent cliff · Toxoplasmosis associated with acquired immunodeficiency syndrome CI report
- Treatment: Sulfadiazine · Eli Lilly
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing